Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-DM1 and Pertuzumab in HER2-Positive Metastatic Breast Cancer
NCT00875979Phase 2Completed
- Sponsor
- Roche
- Start
- May 2009
- Primary completion
- Aug 2011
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of trastuzumab emtansine in breast cancer, sponsored by Roche. Started May 2009; status: completed.
02
Drugs
trastuzumab emtansine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00875979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00875979.